The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The results are solid enough with any real improvement. However the medical division is now back to being able to supply the demand and being paid as BVC want, as is stated in report, so the price should head back to the 20ish it was before that problem. On top of that the contract for infrastructure, should supply a steady and increased income. This company is is not run in short term ways, this can be seen by many investors as a negative, it isn't, just means we aren't rewarded too easily but the rewards will come!
results, should be good enough to see 10% gain here I think and hope
for the riddler, will I be thanking him for getting involved here, little flurry of buying today, so maybe?
But no trades today!
Application has been made for the admission to trading on AIM of the 13,540,000 new Ordinary Shares issued in relation to the Placing and conversion of BCB's interest in the PCL and it is expected that dealings in the new Ordinary Shares will commence on 9 August 2012.
knows what on share game so am not so happy about that
??? I saw you saying on OPE board it is pump and dump just based on a few idiost postings, OPE is not pump and dump and if Ashok are honest is well undervalued, who knows if they are honest but who knows who is honest on LSE chat. I guess you are more honest than most so sorry for my aspertions!
I bought 200 at 17.99 just now thats better than 24p an hour ago
I just bought the shares and lost the money
doing a pump and dump?
announcement, which has just been made. Am not able to judge what impact would/will be, anyone wiser than me (not that difficult to be)
PuriCore(LSE: PURI), on 17/1/2012 announced it has received confirmation from the US Environmental Protection Agency (EPA) for its Aqualox System as an oil and gas biocide. The Aqualox System generates on-site a proprietary, environmentally safe biocidal solution formulated for applications including in the oil and gas industry to treat hydraulic fracturing (or frac) water, which is used to open deep subterranean natural gas reserves. Aqualox is a highly effective biocide that does not damage fracking stimulation fluids and gel agents or cause corrosion. Fracking is an enviromental pariah for the oil industry atr the moment, so something that will resolve some issues with it must be very positive .... however I am not an expert in this and I also believe Fracking has many other problems! My understanding is it is vital to recovering oil and gas (frrom shale etc????) that will be much needed in the future, so PURI may have a winner here?
Further to last post, I think capital gains would not apply assuming you have other losses on shares you could write off gains against. Not sure that would apply to income?
Best option is whichever you will pay less tax on. If you work probably capital is the choice, additional income would incur more tax. Unless for some reason you are lucky enough to have a lot of capital gains! I am not a tax expert but thats how I see it!
so Astaire is to delist, after Corporate Synergy spunked £800000 and paid £500000 in costs to Imodia or whatever they were, a company with a mutual director. So still should be worth more than theoretical current capital value. Astaire think it will be in best interest of shareholders to delist, reducing market costs. Shareholders (surprisingly mistrusting) , obviously think otherwise, and consequently price nearly halfed. I not learning lesson despite resolving to sell have sat on my shares to be stuffed, by E vanDyk and his dodgy cronies. I am changing my name on here to shareidiot and everyone should ignore my posts, hang on they do that anyway! Info for newbies just in case!
your charting point obviously stirred this into some action, good job!
Andrew Christopher Roberts director of Astaire Group is on board of Izodia plc. Same Izodia involved in litigation against Corporate Synergy Holdings part of Astaire. Is this not a conflict? CS Holdings has some £3 million being held because of this, thats more than rest of Groups supposed worth to be realised.
Its gone for now but only if this is never unsuspended. I read somewhere after the 18/3/2011 suspension that VYKE issue would be cancelled in one calendar month if the could not get a new nominated advisor which they havn't given any notice of. So they should be cancelled meaning you will have almost certainly lost the £400. But they haven't AIM like FSA are a bunch of ******s who are powerless to stop people like VYKE screwing people like us (more ******s)
there could be some slightly better return had here .... here is essence sharecast from Feb Astaire Group has agreed to sell its last remaining operating subsidiary Rowan Dartington and this could enable it to return some cash to shareholders even though the AIM-quoted company is receiving loan notes and shares in consideration. *****there is no doubt that much more has been/will be realised than the £0.71 mill capital currently figured, the doubt is will this slippery bunch share it out*********maybe they have to??? In a complicated deal, RDH, which was formed by a consortium of private investors led by Graham Coxell, will issue £1m of loan notes, repayable in five years or on a sale of the business, and 30% of its shares to Astaire in return for acquiring Rowan Dartington. The investors will own the other 70% of RDH and they will invest £800,000 in RDH loan notes to provide working capital. There are a number of potential cash adjustments relating to the sale, including the purchase by Astaire of £650,00 of investments in Rowan Dartington's Isambard Fund. Assuming that the sale of Dowgate Capital Stockbrokers goes ahead as planned, Astaire will have £930,000 of cash with a further £362,000 in escrow relating to the sale of Astaire Securities. A subsidiary, CS Group, has £3m in cash but this is being kept in this company to cover any expenses and claims relating to the litigation with Izodia. Once liabilities, including tax, are covered Astaire will consider any excess cash to shareholders - not including the CS cash. Astaire does have some quoted and unquoted investments, including a stake in Euroclear. These will be liquidated over time but there will be no fire sale. There are no immediate plans to cancel the AIM quotation.